Q9997 Ustekinumab-ttwe intravenous injection 1 milligrams
Also known as: ustekinumab, IL-12/23 inhibitor, Stelara
Injection of ustekinumab-ttwe (Stelara), administered intravenously at 1 milligram per dose.
In Plain Language
immune system blocker; skin disease treatment; autoimmune medication
Clinical Context
Used for intravenous administration of ustekinumab for immunosuppressive therapy in TNF-mediated inflammatory diseases.
RVU Information
CPT Q9997 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Q-codes are temporary HCPCS codes used when no permanent code exists. Coverage and reimbursement vary by payer and region. Document the clinical indication and medical necessity. These codes may be replaced by permanent codes in future HCPCS updates.
Specialties
Frequently Asked Questions
What is CPT code Q9997?
CPT Q9997 (Ustekinumab-ttwe intravenous injection 1 milligrams) is a Q Codes code. Injection of ustekinumab-ttwe (Stelara), administered intravenously at 1 milligram per dose.
Is Q9997 covered by insurance?
Q9997 is a temporary HCPCS code. Coverage varies by payer and may change when permanent codes are assigned. Used for intravenous administration of ustekinumab for immunosuppressive therapy in TNF-mediated inflammatory diseases.
When is CPT Q9997 used?
Used for intravenous administration of ustekinumab for immunosuppressive therapy in TNF-mediated inflammatory diseases.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.